BIT
XPH icon

BlackRock Institutional Trust’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

BlackRock Institutional Trust’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10
Closed – – 4048
2013
Q2 		$0 Buy
+10
New +$338 ﹤0.01% 3977

Other funds holding XPH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EC
Estate Counselors Thiensville, Wisconsin $1.12B AUM 20.13% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

BlackRock Institutional Trust's XPH Position: Q3 2013 in Review

BlackRock Institutional Trust sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2013, closing a stake of 10 shares.

BlackRock Institutional Trust first reported a position in XPH in Q2 2013 and held it in 1 quarter. The position peaked at $0 in Q2 2013. 55 funds tracked by Wall St. Rank hold XPH as of Q3 2013.

  • BlackRock Institutional Trust reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2013 after selling out during the quarter.
  • BlackRock Institutional Trust sold 10 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2013.
  • BlackRock Institutional Trust first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 1 quarter.
  • BlackRock Institutional Trust's State Street SPDR S&P Pharmaceuticals ETF position peaked at $0 in Q2 2013.
  • 55 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2013.

Based on BlackRock Institutional Trust's 13F filing for Q3 2013, filed 12 Nov 2013.